Dachaigh › Paraganglioma
Sgrùdaidhean clionaigeach Paraganglioma a’ fastadh anns na SA
Tha 14 sgrùdaidhean airson Paraganglioma a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
Le stàit
- California3 sgrùdaidhean
- Maryland7 sgrùdaidhean
- Michigan3 sgrùdaidhean
- Pennsylvania3 sgrùdaidhean
- Tennessee3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06041516Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07282587[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06479811Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04924075Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
A’ fastadhÌre 2
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03206060Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
A’ fastadhÌre 1/2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06427798Using the EHR to Advance Genomic Medicine Across a Diverse Health System
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT06377033Familial Investigations of Childhood Cancer Predisposition
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT0305026818F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
A’ fastadhÌre 2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT06503146Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
A’ fastadhÌre 1/2
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT05636618Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT04119024In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT0563654068-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
A’ fastadhÌre 4
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 21 Samh 2025 · NCT04081701Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Gach gnè · Air ùrachadh 15 Dàmh 2025 · NCT03160274Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.